Viewing nowCombinationEmpag Duo Tablet 12.5/850 mg (Empagliflozin, Metformin Hydrochloride)
Empagliflozin 12.5mg · Metformin Hydrochloride 850mg
Tablet · Prescription medication · Combination
Dongwoo Bio Pharmaceutical Co., Ltd.

MFDS item code 202302303 · Approved 2023.07.31 · Insurance code 657309100
Improvement of glycemic control in adults with type 2 diabetes mellitus
This medication is used as an adjunct to diet and exercise to improve blood sugar control in adults with type 2 diabetes. It is particularly used in patients whose blood sugar is not adequately controlled with diet and exercise alone. Empagliflozin is used in combination with Metformin for these patients. Also, in patients with cardiovascular disease, caution is needed regarding the risk of cardiovascular events; hence, the use should be guided by a healthcare professional. This medication aids in diabetes treatment through effective blood sugar management.
The recommended dosage of this medicine is 1 tablet twice daily. The dose should be determined based on each patient's current treatment regimen, efficacy, and tolerability, without exceeding the maximum recommended daily doses of each component: empagliflozin 25 mg and metformin 2000 mg. For patients whose blood glucose is not adequately controlled with metformin alone or in combination with other medicines such as insulin, the recommended dose when starting this medicine is empagliflozin 5 mg twice daily (total daily dose 10 mg) and the patient's current metformin dose. If empagliflozin 10 mg (total daily dose) is well tolerated and additional glycemic control is needed, the dose may be increased to empagliflozin 25 mg (total daily dose). Patients switching to this medicine from combination therapy with empagliflozin (total daily dose 10 mg or 25 mg) and metformin should receive their previous doses of empagliflozin and metformin. When this medicine is coadministered with a sulfonylurea or insulin, a reduction in the dose of the sulfonylurea or insulin may be considered to reduce the risk of hypoglycemia. This medicine should be taken with meals to reduce gastrointestinal adverse reactions associated with metformin. If a dose is missed, take it as soon as you remember. However, do not take a double dose at one time; in this case, skip the missed dose. No dosage adjustment is necessary for patients with mild renal impairment. Because this medicine contains metformin, it may be used with dose adjustment in patients with an estimated glomerular filtration rate (eGFR) of 45-59 ml/min/1.73m2 or a CrCl of 45-59 ml/min who have no other conditions that may increase the risk of lactic acidosis. In these patients, the starting dose of metformin is 500 mg or 850 mg once daily; therefore, treatment should be initiated with the individual components, empagliflozin and metformin. The maximum daily dose of metformin hydrochloride that may be administered as this medicine is 1000 mg, given as 500 mg twice daily. Renal function should be carefully monitored every 3-6 months. If renal function declines to CrCl < 45 ml/min or eGFR < 45 ml/min/1.73m2, this medicine should be discontinued immediately. In patients aged 75 years or older, renal function and the risk of volume depletion should be considered.
This medication can cause rare but serious side effects such as severe lactic acidosis, therefore it should not be used by patients at high risk of this condition. Caution is needed as low blood sugar may occur when used with other diabetes medications. Patients with moderate to severe renal impairment or acute kidney issues should not take this medication. It should also not be used during acute conditions such as severe infections, heart failure, or acute myocardial infarction. Patients undergoing tests with radiocontrast containing iodine must discontinue this medication for a certain period before and after the test, and resume only after confirming normal kidney function. Women who are pregnant or breastfeeding should not take this medication. Elderly patients or those with reduced kidney function should have regular kidney function tests before and during treatment, and should exercise extra caution if there is a risk of fluid loss. This medication may increase the risk of urinary and genital infections, and patients should consult a healthcare professional immediately if symptoms appear. Symptoms of low blood sugar may arise, especially when used in combination with insulin or sulfonylurea medications; therefore, blood glucose levels should be monitored carefully. Long-term use may result in vitamin B12 deficiency, so it is advisable to check serum vitamin B12 levels periodically. Alcohol intake may increase the risk of lactic acidosis; hence, excessive drinking should be avoided during treatment. If fever, genital pain, swelling, or other symptoms occur during treatment, there is a possibility of severe infections such as perineal necrotizing fasciitis, and healthcare professionals must be informed immediately. Patients scheduled for surgery or those with acute illnesses making oral intake difficult should discontinue this medication 48 hours prior to surgery and resume only after kidney function has returned to normal. Blood glucose control should be regularly monitored during treatment, and any unusual symptoms should be reported to a healthcare professional immediately.
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly sealed container to protect it from air and moisture, at room temperature between 1 and 30 degrees Celsius. This storage will help maintain the effectiveness of the drug.
Pinkish white, biconvex, oval-shaped film-coated tablet
60 tablets/box [10 tablets/PTP x 6], 10 tablets/box [10 tablets/PTP x 1], 30 tablets/bottle, 60 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowCombinationEmpagliflozin 12.5mg · Metformin Hydrochloride 850mg
Tablet · Prescription medication · Combination
Dongwoo Bio Pharmaceutical Co., Ltd.
CombinationEmpagliflozin 5mg · Metformin Hydrochloride 500mg
Tablet · Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationEmpagliflozin 5mg · Metformin Hydrochloride 850mg
Tablet · Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationEmpagliflozin 5mg · Metformin Hydrochloride 1000mg
Tablet · Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationEmpagliflozin 12.5mg · Metformin Hydrochloride 500mg
Tablet · Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationEmpagliflozin 12.5mg · Metformin Hydrochloride 850mg
Tablet · Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationEmpagliflozin 12.5mg · Metformin Hydrochloride 1000mg
Tablet · Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationEmpagliflozin 5mg · Metformin Hydrochloride 500mg
Tablet · Prescription medication · Combination
Donggu Bio Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.